DAAAK Pharma Int. AS

Aktsiaselts · 12864378 · Registrisse kantud

Activity

DAAAK Pharma Int. AS is a small enterprise in trade, with declared activity “Ravimite ja muude apteegikaupade hulgimüük” (EMTAK 46461). Annual revenue stands at 7.57 M € with 11 employees, ranks #664 of 27,752 in trade.

Trade

Overview (2025)

Revenue
7.57 M €
▼ 28.4%YoY
▲ 312×above industry median
Profit
60.4 k €
▲ 120%YoY
Profit margin
0.8%
Employees
11
▼ 26.7%YoY
Revenue per employee
687.7 k €
Cost per employee
-26.1 k €
Equity
2.55 M €

Growth

Revenue
7.57 M €
▼ 28.4%
1y
▲ 22.8%
3y CAGR
▲ 12.2%
5y CAGR
Profit
60.4 k €
▲ 120%
1y
▼ 47.2%
3y CAGR
▼ 13.8%
5y CAGR
Employees
11
▼ 26.7%
1y
▲ 3.2%
3y CAGR
▼ 3.3%
5y CAGR

Trends

Revenue trend
7.57 M €
Profit trend
60.4 k €
Headcount trend
11

Revenue to profit

7.6 M €Revenue−7.5 M €Other costs60 k €Profit

Capital structure

  • Equity77%
  • Liabilities23%

Financials

YearRevenueGrowthProfitMarginEmployeesRevenue per employeeEquity
2025 ✓7.57 M €▼ 28.4%60.4 k €1%11687.7 k €2.55 M €
2024 ✓10.57 M €▼ 39.4%-296.3 k €-3%15704.7 k €2.49 M €
2023 ✓17.44 M €▲ 327%2.49 M €14%111.59 M €2.79 M €
2022 ✓4.09 M €▼ 15.8%410.3 k €10%10408.8 k €695.9 k €
2021 ✓4.86 M €▲ 14.3%-198.6 k €-4%10485.8 k €535.6 k €
2020 ✓4.25 M €—127.0 k €3%13326.8 k €794.2 k €
2019 ✓———————

Similar companies

Same industry, comparable revenue.

Official announcements

Bankruptcy notices, liquidation notices, and other official statements about the company.

View announcements on Ametlikud Teadaanded →

Court rulings

Public court decisions where the company or its registry code is mentioned.

Search court rulings on Riigi Teataja →

General info

Beneficial owners

Individuals who ultimately own or control the company.

Board (1)